調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecast to 2026

乳房再建術の世界市場予測（～2026）：製品別、処置別、種類別、エンドユーザー別

◆タイトル：Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecast to 2026
◆商品コード：MD7670-22
◆調査・発行会社：MarketsandMarkets
◆発行日：2022年3月11日
◆ページ数：241
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥0	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥0	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥0	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界の乳房再建術市場規模が、2021年567百万ドルから2026年647百万ドルまで年平均2.7％成長すると予測しています。本調査レポートは、乳房再建術の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（乳房インプラント、組織拡張器、無細胞皮膚マトリックス）分析、処置別（即時、遅延、修正）分析、種類別（片側、両側）分析、エンドユーザー別（病院、美容クリニック・外来手術センター）分析、地域別分析、競争状況、企業情報など、以下の構成でまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の乳房再建術市場規模：製品別（乳房インプラント、組織拡張器、無細胞皮膚マトリックス）
・世界の乳房再建術市場規模：処置別（即時、遅延、修正）
・世界の乳房再建術市場規模：種類別（片側、両側）
・世界の乳房再建術市場規模：エンドユーザー別（病院、美容クリニック・外来手術センター）
・世界の乳房再建術市場規模：地域別
・競争状況
・企業情報

“The global breast reconstruction market size is projected to reach USD 647 million by 2026 from USD 567 million in 2021, at a CAGR of 2.7%.”
Growth in this industry is driven by the rising incidences of breast cancer, increasing awareness, and the availability of reimbursements. However, clinical risks and complications associated with breast reconstruction restrain the market growth.

“The acellular dermal matrix segment is anticipated to grow at the fastest growth rate during the forecast period.”
The breast reconstruction market, by product, is categorized into breast implants, tissue expanders, and acellular dermal matrix. The acellular dermal matrix segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the rising incidences of breast cancer, increasing number of mastectomies, and growing use usage of acellular dermal matrices.

“The immediate procedure segment is estimated to grow at a rapid rate during the forecast period.”
On the basis of procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. Immediate procedures are expected to remain the fastest-growing segment of the global breast reconstruction market during the breast reconstruction period. Factors such as the increasing number of surgeries post-mastectomy and rising awareness are driving the market.

“Asia Pacific is estimated to register the highest CAGR during the study period.”
Geographically, the breast reconstruction market is dominated by North America and Europe. However, the Asia Pacific market is estimated to grow at the fastest rate during the forecast period.

Breakdown of Profiles of Primary Participants:
• By Company Type: Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation: C-level: 30%, Director-level: 34%, and Others: 36%
• By Region: North America: 40%, Europe: 28%, Asia Pacific: 20%, and the Rest of the World: 12%

The key players in the breast reconstruction market include Mentor Worldwide LLC (Johnson & Johnson) (US), Allergan Aesthetics (An AbbVie Company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), and Sientra (US).

Research Coverage:
The report analyzes the breast reconstruction market by product, procedure, type, end user, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use either or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the products of the top players in the breast reconstruction market
• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of the leading players in the breast reconstruction market
• Market Development: Detailed information about emerging markets
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the breast reconstruction market

【レポートの目次】

1 INTRODUCTION 37
1.1 OBJECTIVES OF THE STUDY 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 38
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 YEARS CONSIDERED FOR THE STUDY 39
1.4 CURRENCY 39
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 39
1.5 LIMITATIONS 40
1.6 STAKEHOLDERS 40
1.7 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
FIGURE 1 RESEARCH DESIGN 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Secondary sources 44
2.1.2 PRIMARY DATA 44
FIGURE 2 PRIMARY SOURCES 45
2.1.2.1 Key data from primary sources 46
2.1.2.2 Key industry insights 47
2.1.2.3 Breakdown of primary interviews: By company type,
designation, and region 47
2.2 MARKET SIZE ESTIMATION 48
FIGURE 3 REVENUE SHARE ANALYSIS ILLUSTRATION: SIENTRA. 48
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF BREAST RECONSTRUCTION PRODUCTS AND SERVICES 49
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50
FIGURE 6 TOP-DOWN APPROACH 51
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 52
FIGURE 7 DATA TRIANGULATION METHODOLOGY 52
2.4 MARKET SHARE ANALYSIS 53
2.5 ASSUMPTIONS FOR THE STUDY 53
2.6 LIMITATIONS 53
2.6.1 METHODOLOGY-RELATED LIMITATIONS 53
2.7 RISK ASSESSMENT 54
TABLE 2 RISK ASSESSMENT: BREAST RECONSTRUCTION MARKET 54
2.8 COVID-19 HEALTH ASSESSMENT 54
2.9 COVID-19 ECONOMIC ASSESSMENT 55
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 55
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 55
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 57
3 EXECUTIVE SUMMARY 58
FIGURE 10 BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 58
FIGURE 11 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION) 59
FIGURE 12 BREAST RECONSTRUCTION MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 59
FIGURE 13 BREAST RECONSTRUCTION MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 60
FIGURE 14 BREAST RECONSTRUCTION MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 61
4 PREMIUM INSIGHTS 62
4.1 BREAST RECONSTRUCTION MARKET OVERVIEW 62
FIGURE 15 RISING INCIDENCES OF BREAST CANCER EXPECTED TO DRIVE THE GROWTH OF THE MARKET DURING THE FORECAST PERIOD 62
4.2 BREAST RECONSTRUCTION BREAST IMPLANTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 63
FIGURE 16 SILICONE IMPLANT SEGMENT TO GROW AT A CAGR
DURING HE FORECAST PERIOD 63
4.3 NORTH AMERICA: BREAST RECONSTRUCTION MARKET,
BY PRODUCT AND COUNTRY (2020) 63
FIGURE 17 BREAST IMPLANTS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020 63
4.4 BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2021–2026 64
FIGURE 18 IMMEDIATE PROCEDURE SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026) 64
4.5 BREAST RECONSTRUCTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 65
FIGURE 19 THE BREAST RECONSTRUCTION MARKET IN CHINA EXPECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 20 BREAST RECONSTRUCTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing incidence of breast cancer 67
TABLE 3 TOP 10 COUNTRIES WITH THE HIGHEST INCIDENCE OF
BREAST CANCER, 2020 67
TABLE 4 INCIDENCE OF BREAST CANCER, 2018 VS. 2020 VS. 2025 68
5.2.1.2 Growing aging population 68
5.2.1.3 Increasing awareness regarding breast reconstruction treatment 68
5.2.1.4 Improving reimbursements for breast reconstruction procedures 69
TABLE 5 CPT CODES FOR BREAST RECONSTRUCTION 69
5.2.2 RESTRAINTS 70
5.2.2.1 Clinical risks and complications of breast reconstruction procedures 70
5.2.2.2 Alternative non-surgical methods 70
5.2.3 OPPORTUNITIES 70
5.2.4 HIGH MARKET GROWTH POTENTIAL IN EMERGING ECONOMIES 70
5.2.4.1 Development of 3D-printed implants 71
5.2.4.2 Rise in preference for biological products 71
5.2.5 CHALLENGES 72
5.2.5.1 Product failures and recalls 72
5.2.5.2 Dearth of trained professionals 72
5.2.6 COVID-19 IMPACT ON THE BREAST RECONSTRUCTION MARKET 72
5.3 RANGES/SCENARIOS 73
5.3.1 BREAST RECONSTRUCTION MARKET 73
FIGURE 21 PESSIMISTIC SCENARIO 73
FIGURE 22 OPTIMISTIC SCENARIO 74
FIGURE 23 REALISTIC SCENARIO 74
5.4 TARIFF AND REGULATORY LANDSCAPE 75
5.4.1 NORTH AMERICA 75
5.4.1.1 US 75
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION 75
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
5.4.1.2 Canada 76
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
TABLE 9 BREAST LESION LOCALIZATION DEVICES CLASSIFICATION ACCORDING TO THE GOVERNMENT OF CANADA 77
5.4.2 EUROPE 77
FIGURE 24 EUROPE: CLASS III MEDICAL DEVICES 77
5.4.3 ASIA PACIFIC 78
5.4.3.1 Japan 78
TABLE 10 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 78
5.4.3.2 China 78
TABLE 11 NMPA MEDICAL DEVICES CLASSIFICATION 79
5.4.3.3 India 79
5.5 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 12 BREAST RECONSTRUCTION MARKET: PORTER’S FIVE FORCES ANALYSIS 79
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 80
5.5.2 BARGAINING POWER OF SUPPLIERS 80
5.5.3 BARGAINING POWER OF BUYERS 80
5.5.4 THREAT OF SUBSTITUTES 80
5.5.5 THREAT OF NEW ENTRANTS 80
5.6 TECHNOLOGY ANALYSIS 81
5.7 VALUE CHAIN ANALYSIS 82
FIGURE 25 VALUE CHAIN ANALYSIS FOR THE BREAST RECONSTRUCTION MARKET 82
5.8 SUPPLY CHAIN ANALYSIS 82
FIGURE 26 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 83
5.9 PATENT ANALYSIS 84
5.9.1 PATENT GRANTED TRENDS FOR BREAST RECONSTRUCTION 84
FIGURE 27 PATENT GRANTED TRENDS OF BREAST IMPLANTS,
JANUARY 2011–FEBRUARY 2022 84
FIGURE 28 PATENT GRANTED TRENDS OF ACELLULAR DERMAL MATRIX,
JANUARY 2011– FEBRUARY 2022 85
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 85
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BREAST IMPLANTS PATENTS, JANUARY 2011—FEBRUARY 2022 86
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ACELLULAR DERMAL MATRIX, JANUARY 2011—FEBRUARY 2022 86
5.10 TRADE ANALYSIS 87
TABLE 13 IMPORT DATA FOR HS CODE 902190 – ARTICLES AND APPLIANCES, WHICH ARE WORN OR CARRIED, OR IMPLANTED IN THE BODY, TO COMPENSATE FOR A DEFECT OR DISABILITY (EXCLUDING ARTIFICIAL PARTS OF THE BODY, COMPLETE HEARING AIDS, AND COMPLETE PACEMAKERS FOR STIMULATING HEART MUSCLES), BY COUNTRY, 2016–2020 (USD MILLION) 87
TABLE 14 EXPORT DATA FOR HS CODE 902190 – ARTICLES AND APPLIANCES, WHICH ARE WORN OR CARRIED, OR IMPLANTED IN THE BODY, TO COMPENSATE FOR A DEFECT OR DISABILITY (EXCLUDING ARTIFICIAL PARTS OF THE BODY, COMPLETE HEARING AIDS, AND COMPLETE PACEMAKERS FOR STIMULATING HEART MUSCLES), BY COUNTRY, 2016–2020 (USD MILLION) 88
5.11 PRICING ANALYSIS 88
TABLE 15 PRICE OF BREAST RECONSTRUCTION PRODUCTS (USD) 88
TABLE 16 AVERAGE COST OF BREAST RECONSTRUCTION SURGERY
USING IMPLANTS (USD) 88
5.12 KEY CONFERENCES & EVENTS IN 2022-2023 89
TABLE 17 BREAST RECONSTRUCTION MARKET: DETAILED LIST OF CONFERENCES & EVENTS 89
5.13 ECOSYSTEM ANALYSIS 91
FIGURE 31 ECOSYSTEM OF THE BREAST HEALTH INDUSTRY 91
5.13.1 ROLE IN THE ECOSYSTEM 92
FIGURE 32 KEY PLAYERS IN THE BREAST RECONSTRUCTION ECOSYSTEM 93
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR BREAST RECONSTRUCTION PRODUCTS MANUFACTURERS OR SERVICE PROVIDERS 94
FIGURE 33 REVENUE SHIFT FOR BREAST RECONSTRUCTION PRODUCTS 94

6 BREAST RECONSTRUCTION MARKET, BY PRODUCT 95
6.1 INTRODUCTION 96
TABLE 18 US: PRODUCTS USED FOR BREAST RECONSTRUCTION PROCEDURES, 2020 96
TABLE 19 BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 96
TABLE 20 BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 96
6.2 BREAST IMPLANT 97
TABLE 21 US: TYPES OF BREAST IMPLANTS USED FOR BREAST RECONSTRUCTION PROCEDURES, 2020 97
TABLE 22 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY REGION, 2018–2020 (USD MILLION) 97
TABLE 23 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY REGION, 2021–2026 (USD MILLION) 98
6.2.1 BREAST IMPLANTS MARKET, BY TYPE 98
TABLE 24 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY TYPE,
2018–2020 (USD MILLION) 98
TABLE 25 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY TYPE,
2021–2026 (USD MILLION) 98
6.2.1.1 Silicone implants 99
6.2.1.1.1 Silicone breast implants expected to dominate the breast implants market due to their benefits 99
TABLE 26 SILICONE BREAST IMPLANTS MARKET, BY REGION,
2018–2020 (USD MILLION) 99
TABLE 27 SILICONE BREAST IMPLANTS MARKET, BY REGION,
2021–2026 (USD MILLION) 99
6.2.1.2 Saline Implants 100
6.2.1.2.1 Low cost of implants to drive market growth 100
TABLE 28 SALINE IMPLANTS MARKET, BY REGION, 2018–2020 (USD MILLION) 100
TABLE 29 SALINE IMPLANTS MARKET, BY REGION, 2021–2026 (USD MILLION) 100
6.2.2 BREAST IMPLANTS MARKET, BY SHAPE 101
TABLE 30 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 101
TABLE 31 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 101
6.2.2.1 Round implants 101
6.2.2.1.1 Round implants show the highest end-user demand and market growth 101
TABLE 32 ROUND BREAST IMPLANT MARKET, BY REGION, 2018–2020 (USD MILLION) 102
TABLE 33 ROUND BREAST IMPLANT MARKET, BY REGION, 2021–2026 (USD MILLION) 102
6.2.2.2 Anatomical implants 102
6.2.2.2.1 Increasing implant-based breast reconstruction procedures will support the market growth 102
TABLE 34 ANATOMICAL BREAST IMPLANT MARKET, BY REGION,
2018–2020 (USD MILLION) 103
TABLE 35 ANATOMICAL BREAST IMPLANT MARKET, BY REGION,
2021–2026 (USD MILLION) 103
6.3 TISSUE EXPANDER 103
6.3.1 RISING NUMBER OF BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH 103
TABLE 36 BREAST RECONSTRUCTION MARKET FOR TISSUE EXPANDER, BY REGION, 2018–2020 (USD MILLION) 104
TABLE 37 BREAST RECONSTRUCTION MARKET FOR TISSUE EXPANDER, BY REGION, 2021–2026 (USD MILLION) 104
6.4 ACELLULAR DERMAL MATRIX 104
6.4.1 RISING NUMBER OF ACELLULAR DERMAL MATRIX BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH 104
TABLE 38 BREAST RECONSTRUCTION MARKET FOR ACELLULAR DERMAL MATRIX,
BY REGION, 2018–2020 (USD MILLION) 105
TABLE 39 BREAST RECONSTRUCTION MARKET FOR ACELLULAR DERMAL MATRIX,
BY REGION, 2021–2026 (USD MILLION) 105
7 BREAST RECONSTRUCTION MARKET, BY PROCEDURE 106
7.1 INTRODUCTION 107
TABLE 40 US: IMMEDIATE AND DELAYED BREAST RECONSTRUCTION PROCEDURES PERFORMED, 2020 107
TABLE 41 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 107
TABLE 42 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 107
7.2 IMMEDIATE PROCEDURES 108
7.2.1 IMMEDIATE PROCEDURES WAS THE LARGEST MARKET SEGMENT 108
TABLE 43 IMMEDIATE BREAST RECONSTRUCTION PROCEDURES MARKET,
BY REGION, 2018–2020 (USD MILLION) 108
TABLE 44 IMMEDIATE BREAST RECONSTRUCTION PROCEDURES MARKET,
BY REGION, 2021–2026 (USD MILLION) 109
7.3 DELAYED PROCEDURES 109
7.3.1 RISING AWARENESS WILL SUPPORT MARKET GROWTH 109
TABLE 45 DELAYED BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION) 109
TABLE 46 DELAYED BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION) 110
7.4 REVISION PROCEDURES 110
7.4.1 DISSATISFACTION AND AESTHETIC ISSUES DRIVE DEMAND FOR REVISION 110
TABLE 47 REVISION BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION) 110
TABLE 48 REVISION BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION) 111

8 BREAST RECONSTRUCTION MARKET, BY TYPE 112
8.1 INTRODUCTION 113
TABLE 49 US: UNILATERAL AND BILATERAL BREAST RECONSTRUCTION PROCEDURES PERFORMED, 2020 113
TABLE 50 BREAST RECONSTRUCTION MARKET, BY TYPE, 2018–2020 (USD MILLION) 113
TABLE 51 BREAST RECONSTRUCTION MARKET, BY TYPE, 2021–2026 (USD MILLION) 113
8.2 UNILATERAL BREAST RECONSTRUCTION 114
8.2.1 UNILATERAL RECONSTRUCTION DOMINATES THE MARKET, BY TYPE 114
TABLE 52 UNILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,
2018–2020 (USD MILLION) 114
TABLE 53 UNILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,
2021–2026 (USD MILLION) 114
8.3 BILATERAL 115
8.3.1 APAC TO SHOW HIGHEST GROWTH IN THE MARKET FOR BILATERAL
BREAST RECONSTRUCTION 115
TABLE 54 BILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,
2018–2020 (USD MILLION) 115
TABLE 55 BILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,
2021–2026 (USD MILLION) 115
9 BREAST RECONSTRUCTION MARKET, BY END USER 116
9.1 INTRODUCTION 117
TABLE 56 BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 117
TABLE 57 BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 117
9.2 HOSPITALS 117
9.2.1 HOSPITALS TO DOMINATE THE BREAST RECONSTRUCTION MARKET DURING THE FORECAST PERIOD 117
TABLE 58 BREAST RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION,
2018–2020 (USD MILLION) 118
TABLE 59 BREAST RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION,
2021–2026 (USD MILLION) 118
9.3 COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS 119
9.3.1 GROWING PREFERENCE FOR OUTPATIENT TREATMENT AND PROCEDURES OVER HOSPITAL CARE DRIVES MARKET GROWTH 119
TABLE 60 BREAST RECONSTRUCTION MARKET FOR COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2020 (USD MILLION) 119
TABLE 61 BREAST RECONSTRUCTION MARKET FOR COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2021–2026 (USD MILLION) 119
9.4 COVID-19 ANALYSIS 120

10 BREAST RECONSTRUCTION MARKET, BY REGION 121
10.1 INTRODUCTION 122
TABLE 62 BREAST RECONSTRUCTION MARKET, BY REGION,
2018–2020 (USD MILLION) 122
TABLE 63 BREAST RECONSTRUCTION MARKET, BY REGION,
2021–2026 (USD MILLION) 122
10.2 NORTH AMERICA 123
FIGURE 34 NORTH AMERICA: BREAST RECONSTRUCTION MARKET SNAPSHOT 124
TABLE 64 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2018–2020 (USD MILLION) 124
TABLE 65 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 125
TABLE 66 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 125
TABLE 67 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 125
TABLE 68 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 126
TABLE 69 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 126
TABLE 70 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 126
TABLE 71 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 127
TABLE 72 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2018–2020 (USD MILLION) 127
TABLE 73 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2021–2026 (USD MILLION) 127
TABLE 74 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 128
TABLE 75 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 128
TABLE 76 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 128
TABLE 77 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 129
10.2.1 US 129
10.2.1.1 The US dominates the North American breast reconstruction market 129
TABLE 78 US: BREAST RECONSTRUCTIVE PROCEDURES PERFORMED IN 2020, BY TYPE 130
TABLE 79 US: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 130
TABLE 80 US: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 130
TABLE 81 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 131
TABLE 82 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 131
TABLE 83 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 131
TABLE 84 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 132
TABLE 85 US: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 132
TABLE 86 US: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 132
TABLE 87 US: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 133
TABLE 88 US: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 133
TABLE 89 US: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 133
TABLE 90 US: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 133
10.2.2 CANADA 134
10.2.2.1 Increasing incidence of breast cancer will drive
market growth in Canada 134
TABLE 91 CANADA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 134
TABLE 92 CANADA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 134
TABLE 93 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 135
TABLE 94 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 135
TABLE 95 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 135
TABLE 96 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 136
TABLE 97 CANADA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 136
TABLE 98 CANADA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 136
TABLE 99 CANADA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 137
TABLE 100 CANADA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 137
TABLE 101 CANADA: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 137
TABLE 102 CANADA: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 138
10.3 EUROPE 138
TABLE 103 INCIDENCE OF BREAST CANCER IN EUROPEAN COUNTRIES, 2020 VS. 2040 138
TABLE 104 MASTECTOMY SURGERIES PERFORMED IN EUROPE, BY COUNTRY, 2019 138
TABLE 105 EUROPE: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2018–2020 (USD MILLION) 139
TABLE 106 EUROPE: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 139
TABLE 107 EUROPE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 139
TABLE 108 EUROPE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 140
TABLE 109 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 140
TABLE 110 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 140
TABLE 111 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 141
TABLE 112 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 141
TABLE 113 EUROPE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 141
TABLE 114 EUROPE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 142
TABLE 115 EUROPE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 142
TABLE 116 EUROPE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 142
TABLE 117 EUROPE: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 143
TABLE 118 EUROPE: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 143
10.3.1 GERMANY 143
10.3.1.1 Germany dominates the European breast reconstruction market 143
TABLE 119 GERMANY: BREAST CANCER INCIDENCE, 2018 VS. 2025 143
TABLE 120 GERMANY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 144
TABLE 121 GERMANY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 144
TABLE 122 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 144
TABLE 123 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 145
TABLE 124 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 145
TABLE 125 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 145
TABLE 126 GERMANY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 146
TABLE 127 GERMANY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 146
TABLE 128 GERMANY: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 146
TABLE 129 GERMANY: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 147
TABLE 130 GERMANY: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 147
TABLE 131 GERMANY: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 147
10.3.2 FRANCE 147
10.3.2.1 Rising geriatric population will drive market growth 147
TABLE 132 FRANCE: BREAST CANCER INCIDENCE, 2018 VS. 2025 148
TABLE 133 FRANCE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 148
TABLE 134 FRANCE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 148
TABLE 135 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 148
TABLE 136 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 149
TABLE 137 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 149
TABLE 138 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 149
TABLE 139 FRANCE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 150
TABLE 140 FRANCE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 150
TABLE 141 FRANCE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 150
TABLE 142 FRANCE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 151
TABLE 143 FRANCE: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 151
TABLE 144 FRANCE: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 151
10.3.3 UK 152
10.3.3.1 Rising incidences of breast cancer will support market growth 152
TABLE 145 UK: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 152
TABLE 146 UK: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 152
TABLE 147 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 153
TABLE 148 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 153
TABLE 149 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 153
TABLE 150 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 154
TABLE 151 UK: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 154
TABLE 152 UK: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 154
TABLE 153 UK: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 155
TABLE 154 UK: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 155
TABLE 155 UK: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 155
TABLE 156 UK: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 156
10.3.4 ITALY 156
10.3.4.1 Rising geriatric population in Italy to drive the market 156
TABLE 157 ITALY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 156
TABLE 158 ITALY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 157
TABLE 159 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 157
TABLE 160 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 157
TABLE 161 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 158
TABLE 162 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 158
TABLE 163 ITALY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 158
TABLE 164 ITALY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 159
TABLE 165 ITALY: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 159
TABLE 166 ITALY: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 159
TABLE 167 ITALY: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 159
TABLE 168 ITALY: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 160
10.3.5 SPAIN 160
10.3.5.1 Silicone implants show high acceptance in Spain 160
TABLE 169 SPAIN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 160
TABLE 170 SPAIN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 161
TABLE 171 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 161
TABLE 172 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 161
TABLE 173 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 162
TABLE 174 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 162
TABLE 175 SPAIN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 162
TABLE 176 SPAIN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 163
TABLE 177 SPAIN: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 163
TABLE 178 SPAIN: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 179 SPAIN: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 164
TABLE 180 SPAIN: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 164
10.3.6 REST OF EUROPE 164
TABLE 181 ROE: BREAST CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040 164
TABLE 182 ROE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 165
TABLE 183 ROE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 165
TABLE 184 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 165
TABLE 185 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 166
TABLE 186 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 166
TABLE 187 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 166
TABLE 188 ROE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 167
TABLE 189 ROE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 167
TABLE 190 ROE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 167
TABLE 191 ROE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 192 ROE: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 168
TABLE 193 ROE: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 168
10.4 ASIA PACIFIC 169
FIGURE 35 ASIA PACIFIC: BREAST RECONSTRUCTION MARKET SNAPSHOT 170
TABLE 194 APAC: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2018–2020 (USD MILLION) 170
TABLE 195 APAC: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 171
TABLE 196 APAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 171
TABLE 197 APAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 171
TABLE 198 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 172
TABLE 199 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 172
TABLE 200 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 172
TABLE 201 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 173
TABLE 202 APAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 173
TABLE 203 APAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 173
TABLE 204 APAC: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 174
TABLE 205 APAC: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 174
TABLE 206 APAC: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 174
TABLE 207 APAC: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 175
10.4.1 CHINA 175
10.4.1.1 China accounts for the largest share of the APAC market 175
TABLE 208 CHINA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 175
TABLE 209 CHINA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 176
TABLE 210 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 176
TABLE 211 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 212 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 177
TABLE 213 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 177
TABLE 214 CHINA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 177
TABLE 215 CHINA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 178
TABLE 216 CHINA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 178
TABLE 217 CHINA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 178
TABLE 218 CHINA: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 179
TABLE 219 CHINA: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 179
10.4.2 JAPAN 179
10.4.2.1 Growing awareness of cosmetic surgery to drive the market in Japan 179
TABLE 220 JAPAN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 180
TABLE 221 JAPAN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 180
TABLE 222 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 180
TABLE 223 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 181
TABLE 224 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 181
TABLE 225 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 181
TABLE 226 JAPAN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 182
TABLE 227 JAPAN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 182
TABLE 228 JAPAN: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 182
TABLE 229 JAPAN: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 183
TABLE 230 JAPAN: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 183
TABLE 231 JAPAN: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 183
10.4.3 INDIA 184
10.4.3.1 Market growth in India is primarily driven by the rising incidence of breast cancer 184
TABLE 232 INDIA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 184
TABLE 233 INDIA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 184
TABLE 234 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 185
TABLE 235 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 185
TABLE 236 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 185
TABLE 237 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 186
TABLE 238 INDIA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 186
TABLE 239 INDIA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 186
TABLE 240 INDIA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 187
TABLE 241 INDIA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 187
TABLE 242 INDIA: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 187
TABLE 243 INDIA: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 187
10.4.4 REST OF ASIA PACIFIC 188
TABLE 244 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 188
TABLE 245 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 188
TABLE 246 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 189
TABLE 247 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 189
TABLE 248 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 189
TABLE 249 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 190
TABLE 250 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 190
TABLE 251 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 190
TABLE 252 ROAPAC: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 191
TABLE 253 ROAPAC: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 191
TABLE 254 ROAPAC: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 191
TABLE 255 ROAPAC: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 191

10.5 REST OF THE WORLD 192
TABLE 256 ROW: BREAST CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040 192
TABLE 257 ROW: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 192
TABLE 258 ROW: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 192
TABLE 259 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 193
TABLE 260 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 193
TABLE 261 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 193
TABLE 262 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 194
TABLE 263 ROW: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 194
TABLE 264 ROW: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 194
TABLE 265 ROW: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 195
TABLE 266 ROW: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 195
TABLE 267 ROW: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 195
TABLE 268 ROW: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 195
11 COMPETITIVE LANDSCAPE 196
11.1 OVERVIEW 196
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 196
TABLE 269 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE BREAST RECONSTRUCTION MARKET 196
11.3 REVENUE SHARE ANALYSIS 197
FIGURE 36 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE BREAST RECONSTRUCTION MARKET 198
11.4 MARKET SHARE ANALYSIS 198
FIGURE 37 BREAST RECONSTRUCTION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 199
TABLE 270 BREAST RECONSTRUCTION MARKET: DEGREE OF COMPETITION 199
11.5 COMPETITIVE LEADERSHIP MAPPING 200
FIGURE 38 BREAST RECONSTRUCTION MARKET: COMPETITIVE
LEADERSHIP MAPPING (2020) 201
11.6 COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS 202
FIGURE 39 BREAST RECONSTRUCTION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS (2020) 203
11.7 COMPANY FOOTPRINT 203
TABLE 271 COMPANY FOOTPRINT 204
TABLE 272 COMPANY PRODUCT FOOTPRINT 205
TABLE 273 COMPANY REGIONAL FOOTPRINT 206
11.8 COMPETITIVE BENCHMARKING 207
TABLE 274 BREAST RECONSTRUCTION MARKET: DETAILED LIST OF KEY START-UPS/SMES 207
11.9 COMPETITIVE SCENARIO 208
TABLE 275 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018– FEBRUARY 2022 208
TABLE 276 KEY DEALS, JANUARY 2018– FEBRUARY 2022 209
TABLE 277 OTHER KEY DEVELOPMENTS, JANUARY 2018– FEBRUARY 2022 210
12 COMPANY PROFILES 211
12.1 KEY PLAYERS 211
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON) 211
TABLE 278 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON): BUSINESS OVERVIEW 211
FIGURE 40 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON): COMPANY SNAPSHOT (2020) 212
12.1.2 ALLERGAN AESTHETICS (AN ABBVIE COMPANY) 215
TABLE 279 ALLERGAN AESTHETICS (AN ABBVIE COMPANY): BUSINESS OVERVIEW 215
FIGURE 41 ALLERGAN AESTHETICS (AN ABBVIE COMPANY):
COMPANY SNAPSHOT (2020) 216
12.1.3 RECENT DEVELOPMENTS 217
12.1.4 SIENTRA 219
TABLE 280 SIENTRA: BUSINESS OVERVIEW 219
FIGURE 42 SIENTRA: COMPANY SNAPSHOT (2020) 220
12.1.5 POLYTECH HEALTH & AESTHETICS GMBH 223
TABLE 281 POLYTECH HEALTH & AESTHETICS: BUSINESS OVERVIEW 223
12.1.6 RECENT DEVELOPMENTS 224
12.1.7 GC AESTHETICS 226
TABLE 282 GC AESTHETICS: BUSINESS OVERVIEW 226
12.1.8 SEBBIN 227
TABLE 283 SEBBIN: BUSINESS OVERVIEW 227
12.1.9 ESTABLISHMENT LABS S.A. 228
TABLE 284 ESTABLISHMENT LABS HOLDINGS: BUSINESS OVERVIEW 228
FIGURE 43 ESTABLISHMENT LABS HOLDINGS: COMPANY SNAPSHOT (2020) 228
12.1.10 INTEGRA LIFESCIENCES 230
TABLE 285 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW 230
FIGURE 44 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020) 231
12.1.11 RTI SURGICAL HOLDINGS 233
TABLE 286 RTI SURGICAL HOLDINGS: BUSINESS OVERVIEW 233
FIGURE 45 RTI SURGICAL HOLDINGS: COMPANY SNAPSHOT (2018) 233
12.1.12 IDEAL IMPLANT INCORPORATED 235
TABLE 287 IDEAL IMPLANT INCORPORATED: BUSINESS OVERVIEW 235
12.1.13 LABORATORIES ARION 236
TABLE 288 LABORATORIES ARION: BUSINESS OVERVIEW 236
12.1.14 SILIMED 237
TABLE 289 SILIMED: BUSINESS OVERVIEW 237
12.1.15 GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD. 238
TABLE 290 GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD.: BUSINESS OVERVIEW 238
12.1.16 CEREPLAS 239
TABLE 291 CEREPLAS: BUSINESS OVERVIEW 239
12.1.17 HANSBIOMED 240
TABLE 292 HANSBIOMED: BUSINESS OVERVIEW 240
12.1.18 PRODUCTS OFFERED 240
12.2 OTHER PLAYERS 242
12.2.1 SHANGHAI KANGNING MEDICAL DEVICE 242
12.2.2 PMT CORPORATION 242
12.2.3 PFM MEDICAL 243
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 244
13.1 DISCUSSION GUIDE 244
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 249
13.3 AVAILABLE CUSTOMIZATIONS 251
13.4 RELATED REPORTS 251
13.5 AUTHOR DETAILS 252

★調査レポート[乳房再建術の世界市場予測（～2026）：製品別、処置別、種類別、エンドユーザー別] ( Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecast to 2026 / MD7670-22) 販売に関する免責事項

[乳房再建術の世界市場予測（～2026）：製品別、処置別、種類別、エンドユーザー別] ( Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecast to 2026 / MD7670-22) についてEメールでお問い合わせ

◆関連調査資料◆

世界の肝炎検査/診断市場予測（～2026）：疾患別、技術別、エンドユーザー別、地域別
MD6643 / MarketsandMarkets / 2021年11月29日 / マーケッツアンドマーケッツ社は、肝炎検査/診断の世界市場規模が2021年28億ドルから2026年36億ドルまで、年平均4.7％成長すると予測しています。本調査資料では、世界の肝炎検査/診断市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、疾患別（B型肝炎、C型肝炎、その他肝炎）分析、技術別（ELISA、RDT、PCR、INAAT、その他）分析、エンドユーザー別（病院＆診断研究所、血液銀行、その他）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・肝炎検査/診断の世界市場規模：疾患別（B型肝炎、C型肝炎、その他肝炎）・肝炎検査/診断の世界市場規模：技術別（ELISA、RDT、PCR、INAAT、その他）・肝炎検査/診断の世界市場規模：エンドユーザー別（病院＆診断研究所、血液銀行、その他）・肝炎検査/診断の世界市場規模：地域別...“The global hepatitis testing market is projected to reach USD 3.6 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 4.7% during the forecast period.” The growth of the global hepatitis testing market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis. High cost of nucleic acid tests, lack of mandates for nucleic acid tests in developing countries and unfavorable reimbursement scenarios are expected to restrain hepatitis market growth. Emerging markets, rising technological advancements in molecular diagnostics,...

世界の低侵襲手術用器具市場予測（～2026）：製品別、手術別、エンドユーザー別、地域別
MD3177 / MarketsandMarkets / 2021年9月28日 / マーケッツアンドマーケッツ社は低侵襲手術用器具の世界市場規模が2021年202億ドルから2026年289億ドルまで、年平均7.4%成長すると予想しています。本調査レポートでは、世界の低侵襲手術用器具市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、製品別（ハンドヘルド型器具、インフレーション装置、手術用スコープ、切断器具、ガイド装置）分析、手術別（胸部外科、胃腸外科、整形外科、婦人科外科、美容整形・減量手術）分析、エンドユーザー別（病院・専門クリニック、外来手術センター（ASCS））分析、地域別分析、競争状況、企業情報などを掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場動向・低侵襲手術用器具の世界市場規模：製品別（ハンドヘルド型器具、インフレーション装置、手術用スコープ、切断器具、ガイド装置）・低侵襲手術用器具の世界市場規模：手術別（胸部外科、胃腸外科、整形外科、婦人科外科、美容整形・減量手術）・低侵襲手術用器具の世界市場規模：エンドユーザー別（病院・専門クリニック、外来手術センター（ASCS））・低侵襲手術用器具の世界市場規模：地域別...“The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period.” Market growth is driven by factors such as the increasing adoption of advanced robotics in ASCs, the increasing number of surgical procedures worldwide, and the advantages of MIS over open surgical techniques. On the other hand, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. “The electrosurgical & electrocautery instrumentssegment accounted for...

世界のバイオプロセス容器市場予測（～2026）：種類別、用途別、エンドユーザー別、地域別
BT6176 / MarketsandMarkets / 2021年9月28日 / マーケッツアンドマーケッツ社はバイオプロセス容器の世界市場規模が2021年29億ドルから2026年96億ドルまで、年平均26.3%成長すると予想しています。本調査レポートでは、世界のバイオプロセス容器市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、種類別（2Dバイオプロセス容器、3Dバイオプロセス容器、その他）分析、用途別（上流プロセス、下流プロセス、プロセス開発）分析、エンドユーザー別（製薬・生物医薬品会社、医薬品開発業務受託機関・医薬品製造受託機関、学術・研究機関）分析、地域別分析、競争状況、企業情報などを掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場動向・バイオプロセス容器の世界市場規模：種類別（2Dバイオプロセス容器、3Dバイオプロセス容器、その他）・バイオプロセス容器の世界市場規模：用途別（上流プロセス、下流プロセス、プロセス開発）・バイオプロセス容器の世界市場規模：エンドユーザー別（製薬・生物医薬品会社、医薬品開発業務受託機関・医薬品製造受託機関、学術・研究機関）・バイオプロセス容器の世界市場規模：地域別...“The global bioprocess containers (BPCs) market is projected to grow from USD 2.9 billion in 2021 to USD 9.6 billion by 2026, at a CAGR of 26.3% during the forecast period.” Growth in the bioprocess containers market is mainly driven by factors such as the growing biologics market, affordability and sustainability of single-use bioprocess technologies, and rising biopharmaceutical R&D. Emerging countries and the patent expiry of biologics are expected to offer growth opportunities for players operating in the bioprocess containers market during the forecast period. “By end user segment, the CROs & CMOssegmentaccounted for the fastest-growing segment of thebioprocess containers...

世界のリキッドバイオプシー市場予測（～2026）：製品別、循環バイオマーカー別、技術別、用途別、エンドユーザー別
MD4456 / MarketsandMarkets / 2021年11月30日 / マーケッツアンドマーケッツ社は、リキッドバイオプシーの世界市場規模が2021年25億ドルから2026年58億ドルまで、年平均18.1％成長すると予測しています。本調査資料では、世界のリキッドバイオプシー市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（アッセイキット、機器、サービス）分析、循環バイオマーカー別（CTC、ctDNA、cfDNA、EVS、その他）分析、技術別（NGS式多遺伝子並列分析、PCRマイクロアレイ式単一遺伝子分析）分析、用途別（癌（肺、乳房、前立腺）、癌以外）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・リキッドバイオプシーの世界市場規模：製品別（アッセイキット、機器、サービス）・リキッドバイオプシーの世界市場規模：循環バイオマーカー別（CTC、ctDNA、cfDNA、EVS、その他）・リキッドバイオプシーの世界市場規模：技術別（NGS式多遺伝子並列分析、PCRマイクロアレイ式単一遺伝子分析）・リキッドバイオプシーの世界市場規模：用途別（癌（肺、乳房、前立腺）、癌以外）...“The global liquid biopsy market is projected to reach USD 5.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 18.1% during the forecast period.” Market growth is driven by factors such as the rising incidence & prevalence of cancerand the increasing preference for noninvasive treatment procedures. On the other hand, the lower sensitivity of certain liquid biopsies might act as a restraining factor to the growth of this market. “The assay kits segment accounted for the highest growth rate in theliquid biopsy market, by product& service, during the forecast period” The liquid biopsy market is...

世界の除細動器市場予測（～2026）：製品タイプ別、患者別、エンドユーザー別、地域別
MD3124 / MarketsandMarkets / 2021年11月25日 / マーケッツアンドマーケッツ社は、除細動器の世界市場規模が2021年114億ドルから2026年182億ドルまで、年平均9.7％成長すると予測しています。本調査資料では、世界の除細動器市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（植込み型除細動器、外部型除細動器）分析、患者別（成人患者、小児患者）分析、エンドユーザー別（病院・クリニック・心臓センター、プレホスピタルケア、公共用、代替医療施設、在宅医療）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・除細動器の世界市場規模：種類別（植込み型除細動器、外部型除細動器）・除細動器の世界市場規模：患者別（成人患者、小児患者）・除細動器の世界市場規模：エンドユーザー別（病院・クリニック・心臓センター、プレホスピタルケア、公共用、代替医療施設、在宅医療）・除細動器の世界市場規模：地域別...“The global defibrillator market is expected to reach USD 18.2 billion by 2026 from an estimated USD 11.4 billion in 2021, at a CAGR of 9.7% from 2021 to 2026.” Defibrillators are specialized devices that monitor the heart rhythm and deliver electric shocks to rectify abnormal heart rhythms on detection, and as such, play an important role in the treatment of sudden cardiac arrest. Growth in this market is mainly driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs...

世界の血液スクリーニング市場予測（～2026）：技術別、製品別、エンドユーザー別
MD3687 / MarketsandMarkets / 2021年12月1日 / マーケッツアンドマーケッツ社は、血液スクリーニングの世界市場規模が2021年25億ドルから2026年38億ドルまで、年平均8.4％成長すると予測しています。本調査資料では、世界の血液スクリーニング市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品＆サービス別（試薬＆キット、器具、ソフトウェア＆サービス）分析、技術別（核酸検査、ELISA、迅速検査、ウエスタンブロットアッセイ、次世代シーケンシング）分析、エンドユーザー別（血液銀行、病院）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・血液スクリーニングの世界市場規模：製品＆サービス別（試薬＆キット、器具、ソフトウェア＆サービス）・血液スクリーニングの世界市場規模：技術別（核酸検査、ELISA、迅速検査、ウエスタンブロットアッセイ、次世代シーケンシング）・血液スクリーニングの世界市場規模：エンドユーザー別（血液銀行、病院）・血液スクリーニングの世界市場規模：地域別...“The global blood screening market is projected to reach USD 3.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 8.4% during the forecast period.” Growth in this market is mainly driven by the growing number of blood donations across the world, the rising prevalence of infectious diseases, and the rising demand for donated blood. “The reagents & kits segment accounted for the highest growth rate in the blood screening market, by product & service, during the forecast period." The blood screening market is segmented into reagents & kits, instruments, and software & services based on...

テレラジオロジーの世界市場予測（～2026）：製品・サービス別、画像技術別、エンドユーザー別
HIT7701 / MarketsandMarkets / 2022年1月13日 / マーケッツアンドマーケッツ社は、世界のテレラジオロジー市場規模が2021年73億ドルから2026年148億ドルまで、年平均15.3％成長すると予測しています。本調査レポートは、テレラジオロジーの世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別（サービス、ソフトウェア、ハードウェア）分析、画像技術別（CT、MRI、超音波、X線、マンモグラフィ）分析、エンドユーザー別（病院＆クリニック、診断センター＆研究所）分析、地域別分析、競争状況、企業情報など、以下の構成でまとめております。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界のテレラジオロジー市場規模：製品・サービス別（サービス、ソフトウェア、ハードウェア）・世界のテレラジオロジー市場規模：画像技術別（CT、MRI、超音波、X線、マンモグラフィ）・世界のテレラジオロジー市場規模：エンドユーザー別（病院＆クリニック、診断センター＆研究所）・世界のテレラジオロジー市場規模：地域別...“The teleradiology market is expected to reach USD 14.8 billion by 2026 from USD 7.3 billion in 2021, at a CAGR of 15.3% during the forecast period of 2021 to 2026.” Due to the outbreak of coronavirus globally, there is a sudden rise in the demand for teleradiology services. The growth of this market is mainly attributed to the growth of the teleradiology market is driven by the rising geriatric population and the subsequent increase in the prevalence of associated diseases; the increasing number of advanced imaging procedures and a shortage of skilled radiologists; advancements in teleradiology the increasing adoption...

世界の軍事用ディスプレイ市場予測（～2026）：エンドユーザー別、技術別、種類別、パネルサイズ別、製品別、地域別
AS7981 / MarketsandMarkets / 2021年9月17日 / マーケッツアンドマーケッツ社は軍事用ディスプレイの世界市場規模が2021年11億ドルから2026年14億ドルまで、年平均4.9%成長すると予想しています。本調査レポートでは、世界の軍事用ディスプレイ市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、産業動向、製品別（ハンドヘルド型、コンピューターディスプレイ、車両搭載、ウェアラブル、シミュレータ）分析、エンドユーザー別（陸軍、海軍、空軍）分析、技術別（LCD、LED、OLED、AMOLED）分析、種類別（スマートディスプレイ、従来型ディスプレイ）分析、地域別分析、競争状況、企業情報などを掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場動向・産業動向・軍事用ディスプレイの世界市場規模：製品別（ハンドヘルド型、コンピューターディスプレイ、車両搭載、ウェアラブル、シミュレータ）・軍事用ディスプレイの世界市場規模：エンドユーザー別（陸軍、海軍、空軍）・軍事用ディスプレイの世界市場規模：技術別（LCD、LED、OLED、AMOLED）...“The Military displays market size is forecasted to grow from an estimated USD 1.1 billion in 2021 to reach USD 1.4 billion by 2026, at a CAGR of 4.9% from 2021 to 2026.” Increasing defense spending in the world and new technological developments to help strengthen military capabilities and efficiency is expected to drive the market for military displays across the globe. Increasing geopolitical tensions across regions and overall strengthening activities across the world is triggering the defense spending across these regions. This, in turn, is pushing manufacturers and system component providers to design and manufacture more high technology, high...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆